Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
HoxC11 ChIP-seq of LY2 Breast Cancer Cell Line
PubMed Similar studies SRA Run Selector
SRC-1 targets ADAM22: an ER-independent mechanism of tumour progression in endocrine resistance
PubMed Full text in PMC Similar studies SRA Run Selector
SRC1 gene regulation in endocrine resistant breast cancer cells
PubMed Full text in PMC Similar studies Analyze with GEO2R
ER ChIP-seq of Androstenedione treated Letrozole Resistant Breast Cancer Cell line
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor positive breast cancer
AKT antagonist AZD5363 influences estrogen receptor function in endocrine resistant breast cancer and synergizes with fulvestrant (ICI182780) in vivo
PubMed Similar studies Analyze with GEO2R
Effect of RBP2 on MCF7 breast cancer cells (RNA-seq)
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells
PubMed Similar studies
MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells
PubMed Similar studies Analyze with GEO2RSRA Run Selector
High CDK6 protects cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant in estrogen receptor-positive metastatic breast cancer
Effect of bone marrow microenvironment on the sensitivity of breast cancer cells to antiestrogens
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Synergistic targeting of estrogen-receptor positive breast cancers by MDM2 inhibition in combination with endocrine therapy or CDK4/6 inhibition
Effect of tamoxifen on early gene expression in T47D and MDA-MB-231 cells
Effect of tamoxifen on early gene expression in MDA-MB-231 cells
Effect of tamoxifen on early gene expression in T47D cells
Inhibition of CDK8 Mediator Kinase Suppresses Estrogen Receptor Signaling and Growth of Estrogen Receptor Positive Breast Cancer
Steroid Receptor Coactivator 1 is an Integrator of Glucose and NAD(+)/NADH Homeostasis
Glucose effect on steroid receptor coactivator 1 deficient-A549 lung cancer epithelial cell line
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on